Electrospun-lyophilized chitosan wound dressings for dual bioactive delivery of hyaluronic acid and IL-6
European Journal of Pharmaceutics and Biopharmaceutics · 2026-12 · 229 · 115263
DOI: 10.1016/j.ejpb.2026.115263 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026-12. Verfasst von Annika Horchler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Technology, Goethe-University Frankfurt, Frankfurt am Main, 60438, Germany. Hauptthemen laut MEDLINE: Hyaluronic Acid, Chitosan, Wound Healing, Interleukin-6. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Wound healing is a complex and highly regulated cellular process with limited therapeutic interventions despite its substantial clinical burden. Current research shifts towards endogenous biomolecules as promising wound healing candidates, including hyaluronic acid and interleukin-6. However, despite their clinical potential such molecules pose significant technological challenges due to their fragility, limiting their clinical application. To overcome these limitations, a bilayer wound dressing was developed combining electrospinning and freeze drying. A chitosan nanofiber mat serves as a physical barrier, while hyaluronic acid and interleukin-6 were transformed into a hydrophilic wound-healing-promoting layer via freeze drying, enabling immediate and wound-phase-specific delivery of interleukin-6. Hyaluronic acid acts as a stabilizer for interleukin-6, enhancing its recovery by about 30 % and initial storage stability. The wound dressing demonstrates high biocompatibility, with a cell viability of 126 % and reduces the residual wound area and accelerates wound closure by more than 40 % after 48 h compared to the control. Further, pronounced antibacterial activity of chitosan is proven against Staphylococcus aureus and Pseudomonas aeruginosa, further enhanced by hyaluronic acid through increased protonation of amino groups. These results provide proof-of-concept for the potential of this bilayer system as a multifunctional platform for the stable and effective delivery of fragile biomolecules enabling modern wound therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Technology, Goethe-University Frankfurt, Frankfurt am Main, 60438, Germany.
- Institute of Pharmaceutical Technology, Goethe-University Frankfurt, Frankfurt am Main, 60438, Germany. Electronic address: windbergs@em.uni-frankfurt.de.
Zitieren
APA
Horchler, A., Rau, M. C., Planz, V., & Windbergs, M. (2026). Electrospun-lyophilized chitosan wound dressings for dual bioactive delivery of hyaluronic acid and IL-6. European Journal of Pharmaceutics and Biopharmaceutics, 229, 115263. https://doi.org/10.1016/j.ejpb.2026.115263
Vancouver
Horchler A, Rau MC, Planz V, Windbergs M. Electrospun-lyophilized chitosan wound dressings for dual bioactive delivery of hyaluronic acid and IL-6. European Journal of Pharmaceutics and Biopharmaceutics. 2026;229:115263. doi:10.1016/j.ejpb.2026.115263
BibTeX
@article{Horchler2026,
author = {Horchler, Annika and Rau, Marie-Christine and Planz, Viktoria and Windbergs, Maike},
title = {Electrospun-lyophilized chitosan wound dressings for dual bioactive delivery of hyaluronic acid and IL-6},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2026},
volume = {229},
pages = {115263},
doi = {10.1016/j.ejpb.2026.115263}
}
EUVIMED